Intravenous lidocaine for the treatment of background or procedural burn pain

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Wasiak, Jason ^a   Mahar, Patrick D ^b   Mcguinness, Siobhan K ^c   Spinks, Anneliese ^d   Danilla, Stefan ^e   Cleland, Heather ^c   Tan, Hannah B ^c  

^a EPWORTH HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e Victorian Adult Burns Service ^*  (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; NARCOTIC ANALGESIC AGENT; PLACEBO; INTRAVENOUS ANESTHETIC AGENT; LOCAL ANESTHETIC AGENT;

ANALGESIA; ANXIETY; BURN; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; HUMAN; NAUSEA; PAIN; PAIN ASSESSMENT; PAIN INTENSITY; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN TRANSPLANTATION; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; VOMITING; BURNS; COMPLICATION; PROCEDURES;

ANALGESIA; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; BURNS; HUMANS; LIDOCAINE; PAIN; PAIN MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84921970648     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005622.pub4     Document Type: Review

References (23)

1. Wasiak J, Spinks A, Costello V, Ferraro F, Paul E, Konstantatos A, et al.Adjuvant use of intravenous lidocaine for procedural burn pain relief: a randomized double-blind, placebo-controlled, cross-over trial. Burns 2011;37(6):951-7.
2. Cassuto J, Tarnow P. Potent inhibition of burn pain without use of opiates. Burns 2003;29:163-6.
3. Holthusen H, Irsfeld S, Lipfert P. Effect of pre- or post-traumatically applied i.v. lidocaine on primary and secondary hyperalgesia after experimental heat trauma in humans. Pain 2000;88(3):295-302.
4. Jönsson A, Cassuto J, Hanson B. Inhibition of burn pain by intravenous lignocaine infusion. Lancet 1991;338(8760):151-2.
5. Koppert W, Brueckl V, Weidner C, Schmelz M. Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine. European Journal of Pain 2004;8(3):237-44.
6. Mattsson U, Cassuto J, Tarnow P, Jonsson A, Jontell M. Intravenous lidocaine infusion in the treatment of experimental human skin burns - digital colour image analysis of erythema development. Burns 2000;26(8):710-5.
7. Abelson KS, Hoglund AU. Intravenous administered lidocaine in therapeutic doses increases the intraspinal release of acetylcholine in rats. Neuroscience Letter 2002;317(2):93-6.
8. Attal N, Gaude V, Brasseur L. Intravenous lidocaine in central pain: a double blind, placebo-controlled, psychophysical study. Neurology 2000;54(3):564-74.
9. Dauber A, Osgood PF, Breslau AJ. Chronic persistent pain after severe burns: a survey of 358 burns survivors. Pain Medicine 2002;3:6-17.
10. Edwards AD. The role of systemic lidocaine in neuropathic pain management. Journal of Intravenous Nursing 1999;22(5):273.
11. Edwards RR, Smith MT, Klick B, Magyar-Russell G, Smit M, Weichman P. Symptoms of depression and anxiety as unique predictors of pain-related outcomes following burn injury. Annals of Behavioural Medicine 2007;34(3):313-22.
12. Ferrante F, Michael MD, Paggioli J, Cherukuri S, Richard AG. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesthesia and Analgesia 1996;82(1):91-7.
13. Finn J, Wright J, Fong J, Mackenzie E, Wood F, Leslie G, et al.A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns. Burns 2004;30(3):262-8.
14. Hand PJ, Stark RJ. Intravenous lignocaine infusions for severe chronic daily headache. Medical Journal of Australia 2000;172(4):157-9.
15. Harandi AA, Esfandani A, Shakibaei F. The effect of hypnotherapy on procedural pain and state anxiety related to physiotherapy in women hospitalized in a burn unit. Contemporary Hypnosis 2004;21(1):28-34.
16. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
17. Konstantatos A, Angliss M, Costello V, Cleland H, Stafrace S. Predicting the effectiveness of virtual reality relaxation on pain and anxiety when added to PCA morphine in patients having burns dressing changes. Burns 2009;35(4):491-9.
18. McLeane G. Intravenous infusion of lidocaine is not associated with changes in cardiovascular parameters: a study of 15 patients. The Pain Clinic 2001;13(1):83-6.
19. Meyer RP, Campbell JN. Myelinated nociceptive afferent account for hyperalgesia that follows a burn to the hand. Science 1981;213:1527-9.
20. Richardson P, Mustard L. The management of pain in the burns unit. Burns 2009;35:921-36.
21. Summer GJ, Puntillo KA, Miakowski C, Green PG, Levine JD. Burn injury pain: the continuing challenge. Journal of Pain 2007;8(7):533-48.
22. Zor F, Ozturk S, Bilgin F, Isik S, Cosar A. Pain relief during dressing changes of major adult burns: ideal analgesic combination with ketamine. Burns 2010;36(4):501-5.
23. Wasiak J, Cleland H. Lidocaine for pain relief in burn injured patients. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD005622.pub2]